Status:
COMPLETED
Post Approval Commitment Study
Lead Sponsor:
Endo Pharmaceuticals
Conditions:
Dupuytren's Contracture
Eligibility:
All Genders
18+ years
Brief Summary
An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of Xiapex® as well as other non-pharmacological treatments for Dupuyt...
Detailed Description
phase 4, open label, multi-center, prospective non-interventional descriptive
Eligibility Criteria
Inclusion
- Adults with a palpable cord eligible for the treatment of Dupuytren's contracture
Exclusion
- none
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT01444729
Start Date
March 1 2012
End Date
November 1 2015
Last Update
October 26 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Auxilium Investigational Site
Bergen, Norway, 5021
2
Auxilium Investigational Site
Drammen, Norway, 3004
3
Auxilium Investigational Site
Málaga, Andalusia, Spain, 29010
4
Auxilium Investigational Site
Alcorcón, Madrid, Spain, 28922